However, the tumorigenic properties of ERp46 in RCC cells are not likely related to an inhibitory modulation of adiponectin's tumor-suppressive signaling, as an interaction with AdipoR1 could not be established. This evidence concerns the gene ADIPOQ and renal cell carcinoma.